A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

Inclusion Criteria: The patient will be included if: * Has no medical contraindication * Presents for correction of glabellar furrows, as classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to Hyperkinetic Function (Class 1 or Higher) * Is at least 18 years of age * Signs a written informed consent * Understands and accepts the obligation to present for scheduled follow-up visits * Understands that the GFX procedure may not be successful * Presents at the one month follow-up visit with an improvement from the base line RNKLS score Exclusion Criteria: The patient will be excluded if: * Has had an injection of botulinum toxin to the target area within the previous 4 months and still exhibits a positive cosmetic effect to the glabellar frown. * Has had silicone, fat, collagen or a synthetic material placed in the glabellar region or surgical correction or excision of the glabellar furrows * Has a known bleeding disorder * Pregnant * Has received or is anticipated to receive anti-platelets, anti-coagulants, thrombolytics, or cancer therapy * Is receiving systemic corticosteroids or anabolic steroids (standard doses of inhaled or nasal corticosteroids are acceptable) * Has a history of chronic or recurrent infection or compromised immune system * Has severe allergies manifested by a history of anaphylaxis * Has known lidocaine hypersensitivity * Is enrolled in another study * Has history of keloid formation * The investigator believes the patient is not a suitable candidate for the GFX procedure, or is not likely to receive cosmetic benefitPresents at the one month follow-up visit with no improvement from the base line RNKLS score